Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: A study comparing African Americans and Whites

Urology

Volumn 53, Issue 1, 1999, Pages 187-191

  Barroso Jr, Ubirajara ^a   Oskanian, Peter ^a   Tefilli, Marcos V ^a   Banerjee, Mousumi ^a   Grignon, David ^a   Sakr, Wael ^a   Pontes, Jose Edson ^a   Powell, Isaac J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CAUCASIAN; CONTROLLED STUDY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEGRO; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POPULATION RESEARCH; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATIC NEOPLASMS;

EID: 0344528741     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00441-5     Document Type: Article

References (17)

1. Ries LAG, Hankey BF, and Edwards BK: Cancer statistics review 1973-1987. Bethesda, Maryland, United States Public Health Service, Publication No. 90-2799, 1990.
2. Fowler J.E. Jr, Terrell F. Survival in blacks and whites after treatment for localized prostate cancer. J Urol. 156:1996;133-136.
3. Natarajan N., Murphy G.P., Mettlin C. Prostate cancer in blacks an update from the American Colege of Surgeons Patterns of Care Studies . J Surg Oncol. 40:1989;232-236.
4. Polednak A.P., Flannery J.T. Black versus white. Racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer. 70:1992;2152-2158.
5. Smith D.S., Bullock A.D., Catalona W.J., et al. Racial differences in a prostate cancer screening study. J Urol. 156:1996;1366-1369.
6. Powell I.J., Heilbrun L.K., Sakr W., et al. The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer a multivariate analysis of positive surgical margins . Urology. 49:1997;726-731.
7. Moul J.W., Douglas T.H., McCarthy W.F., et al. Black race is an adverse prognostic factor for prostate cancer recurrence following prostatectomy in an equal access health care setting. J Urol. 155:1996;1667-1673.
8. Moul J.W., Sesterhenn I.A., Connelly R.R., et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 274:1995;1277-1281.
9. NCHS public use tapes 1995 preliminary data - NCHS: US prostate cancer mortality percent change 1991-1995, whites vs. blacks.
10. Petros J.A., Catalona W.J. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer. J Urol. 147:1992;1574-1575.
11. Fournier G.R., Narayan P. Reevaluation of the need for pelvic lymphadenectomy in low grade prostate cancer. Br J Urol. 72:1993;484-488.
12. Bluestein D.L., Bostwick D.G., Bergstralh E.J., et al. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol. 151:1994;1315-1320.
13. Gervasi L.A., Mata J., Earsley J.D., et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol. 142:1989;332-336.
14. Powell I.J., Schwartz K., Hussain M. Removal of the financial barrier to health care does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs System . Urology. 46:1995;825-830.
15. Gomella L.G., White J.L., McCue P.A., et al. Screening for occult nodal metastasis in localized carcinoma of the prostate. J Urol. 149:1993;776-778.
16. Gomella L.G., Raj G.V., Moreno J.G. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urol. 158:1997;326-337.
17. Partin A.W., Yoo J., Carter H.B., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 150:1993;110-114.